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The gene encoding the beta-chain of the T-cell antigen 
receptor (TCR) has been ana lyzed for evidence of rea r-
rangement in skin , blood, and lymph node specimens from 
23 cases o fknowll or suspected cutaneous T -celllym phoma 
(CTCL). Two cutaneous large cell lymphomas, 4 cases of 
Sezary sy ndrom e, and 5 cases of advanced (tumor) sta ges 
of mycosis fun goides sho wed clonal rearrangement of the 
TCR beta- chain gene in all samples, includin g lymph nodes 
in whi ch histologic examination revealed on ly derma to-
T he early recognition of cutaneous T-cell lymphomas (CTCL) constitutes a difficult ta sk for bo th clinicians and hi stopath o logists, and l11u ch effort has been di-rected towards the sea rch for alternative, dia gnosti c criteria, e. g. ultrastructural 11], cell kin etic 12,3] or 
iml11unopheno typic [4-6]. However, whereas these studies have 
provided co nsidera ble inform ation about cellular characteristics 
in CT C L, the hope th at they wou ld aid in the ea rly di agnosis has 
not been fulfill ed [1 -6]. 
Gene m apping with the usc o f DN A probes specifi c for im-
munoglobulin (Ig) hea vy and light chain genes has provided a 
use ful supplement to estab lish c10nality in B-cell tumours (7, 81. 
Recently, cloning of th e genes that encode the beta-chain of the 
antigen specifi c T-cell recepto r (TC R) has provided a comparable 
technique to docum ent c1 0nality in T -ce ll proliferations [9-11]. 
These genes have an o rga nization similar to th at of Ig genes (Fig 
1), und ergo rearrangement ea rl y in T -cell devel opment, 11 2, 13] 
and have been shown to be rearranged in a clonal fashion in most 
T -cell leukemias and lymphomas [14-1 8], including skin and lymph 
node biopsy specimens from advan ced (tumo r) stages of CT C L 
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Abbrev iations: -
C K : kappa chain constant region 
C A : lambda chain constant region 
C T C L: cutaneous T -cell lympho ma 
JII : hea vy chain joining region 
MF: m ycos is fun goidcs 
T C R: T-cell antigen receptor 
pathic lymphadenitis. These results indica te that DNA 
analysis provides a valuable m eans for improvin g the di-
agnosis of extracutaneous disease in advanced stages of 
CTCL. In contrast, the gene was in a germlin e configu-
ration in all sa mples from 12 patients with plague stages 
of mycosis fun goides or suspected ea rly CTCL, suggesting 
that in these 2 conditions the T-cell proliferation is either 
polyclonal or conta ins very few monoclonal (i.e. , neo-
plastic) cells. J fl1IJesI D errl'lalo/ 88: 762-765, 1987 
11 9]. However, the value of such DNA analysis in the early di-
agnosis of C TCL remains unclear. 
In th e present study, the configu ration of th e TCR beta-chain 
gene has been investi gated in skin , blood, and lymph node sam-
ples fro m known or suspected CT C L in an attempt to establish 
th e use fuln ess o f this novel technique in the earl y diagnosis of 
CT C L. 
MATERIAL AND METHODS 
Paticnts Twenty-three patients (17 men and 6 women) fol-
lowed in the Department of D erm atology at th e Finsen Institute 
for periods of between 1-11 years (median , 4 yea rs) were selected 
for study. Their ages ran ged from 15-84 years (median , 67 yea rs). 
T he di agnoses are sUJllm arized in Table I and were based on 
standard clinical [20,21] and histolog ic [22,23] criteria, all ava ilable 
histopathologic specim ens bein g reevaluated by one of the authors 
(EH). 
All cases classifi ed as mycosi s fungoides (including stage II . 
plaque lesions [see Table I]) showed epidermotropic lymphoid 
infiltrates w ith class ical Pautrier mi croabscesses and many pleo-
morphi c lymphoid cell s with large, hyperchro mati c and irregular 
nuclei [231 . In the suspected plaque o r erythrod ermi c lesions (cases 
1-8, sec Table I) , pleomorphic lymphocytes were more infre-
quent. Furthermore, although in these lesions sing le cell exocy-
tosis was usuall y prominent, Pautrier microabscesses cou ld not 
be identified in routinely processed serial sections [24]. 
Clinical Evaluation and Staging SystCITlS The clinica l eval-
uation included ph ysica l exa mination, blood count, chest X-ray, 
and multiple skin biopsies. Patients w ith histo logica lly verified 
malignant cutaneous lymphoma were further investigated by bone 
marrow examination , liver biopsy, IYl11p hangiography, or lymph 
node biopsy [2 1]. 
For m ycos is fun go ides (MF), the staging system proposed by 
th e Scandinavian Mycosis Fungoides Cooperative Group [21] was 
adopted: stage " = plague lesions of MF, no extracutaneous 
disease; sta ge III = tumor lesions of MF, no ex tracutaneous dis-
ease; stage IV = MF w ith enlargement of lymph nodes, showing 
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Figure 1. Stru cturc o f th e TC I{ beta- chain gene. The proccss o f rear-
ra n g em ent occurs prio r to transc ription and in volves the ju xta pos itio n o f 
a va riable (JI), a di vers ity (0 ). and a joining U ) gene sq'; ll1 cnt. Wh ereas 
a beni gn (po lyclonal) T -cell po pu lati on shows lllu itipk diffe rent rear-
ra n gelllent sites (no nc o f w hi ch occur suffi cientl y fr equentl y to be detec ted 
b y t he South ern blo ttin g technique), a malignant T -ce ll po pu latio n rear-
ra n ges thi s gene in an identi ca l o r clonal f.ls hion . T his can be detcc ted as 
add itional (nonge rllliine) bands by SO llthern blo tti ng o f diges tcd. hy-
b r id ized DNA . 
e ither derlllato pathi c lymphadenitis (stage IVa) o r m alig nant Iym-
pho lll J (sta ge IVb) hi sto logica ll y . 
Pa ti ents with cutaneo us large cell no n-H odg kin' s Iymph o lllas 
we r e sta gcd in Kco rd ance with th c Ann Arbo r sys telll 125 1. 
Cells and Tissue Samples Fres h unfi xed bio psy specimcns and 
Ly rnpho pn:p·o iso lated blood m o no nu clca r ce ll s wc rc frozen and 
s t o r cd in liquid nitrogen. Skin spcc imens we re o btaincd as 4 mm 
p Ll n ch b io psies. Fro m indi vidua l patients, 2-13 skin bio psies w crc 
ava ilable fo r thc gcne m apping anal ys is (T able I). In 5 cases (nos. 
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4, 8, 12, 17, and 22, Ta ble I), skin bio psics wc rc o btaiIH:d durin g 
o bse rvati o n periods o f1 -7 m on ths and we rc poo lcd prio r ro O N A 
anal ys is. In these cascs, disease w as stable durin g the obscrva ti on 
perio d bo th clini ca ll y and hisro logicJ ll y. In thc rem aining cascs, 
skin biopsy specimCils werc o btJincd b y takin g multiplc bio psies 
fro lll indi vidual lesio ns. 
All specimcns w erc exa min ed m o rph o log ica ll y (to ass ure rep-
rcsentati ve sJ lllpling) and imlllunocytochemica ll y, usin g stand ard 
imllluno perox id ase r26 1 o r ill1lllunoa lkalin c phos phatase 1271 
stainin g m eth ods and a pa nel o f Ill onoclona l antibo dics aga inst 
lymph o id ce ll s described prev io usly 15J. In 21 cases, the infil-
tratin g cell s ex pressed a helper / induccr (C D4-positi ve, C DS-ncg-
ati ve) phcno typc. In th e relll aining 2 cascs, the neo plas ti c cclls 
sho w cd unusual pheno types in that thcy either co- cx pressed th e 
antigcns C D4 and C DS (case no . 15) o r la cked re~ cti v ity w ith 
bo th Il1~rkers (c~se no. 23, T 3blc 1). 
Contro ls co nsis ted o f sa mples o f tiss uc fro m 2S cascs of ca r-
cino ma and peripllcral blood fro m 36 he::t1th y w hi te voluntccrs. 
DNA Analysis DNA was ex tr~ c tcd fro m frozcn ti ss Ll e biopsy 
specimens (o r pcripheral blood leukocy tes) b y routin e m etho ds 
and di ges ted with end onucleases I'2S]. Thc DNA frag m cnts were 
subj cctcd to elcctro pho res is in O.S% aga rosc gc ls and transferrcd 
to nitrocc llulose filters by SOLlthern blotting . Filters w ere hy-
bridized w ith J2 P_I~bc l ed pro bcs spccifi c fo r Ig and TC n. genes 
1291, w ashcd under appro pri ate conditi o ns, and subj cctcd to au-
to radi ognph y. Thc 4 pro bcs used in thi s stud y we rc an Ig hca vy-
chain j oining regio n J'I pro be (C76n.5 1 A), an Ig kappa-chain con-
stant reg io n C, pro be (pU C n.-17Ck), an Ig lalllbd ~ -ch a in constant 
Table I. C linica l, IlIlllluno pheno typic, and Geno typic Findings in C utan cous T-cc ll Lymph o m as 
Sa l1lples 
Case" Stlldi ~dl' C D3 
? Ea rl y C T C L 
1 Skin (3) + 
2 Skin (3) + 
3 Skin (3) + 
4 Skin (7) + 
5 Skin (3) + 
6 Skin (3) + 
7 Skin (4) + 
8 Skin ( 13) + 
M F plaqu~, stage II 
9 Skin (4) + 
'10 Skin (3) + 
11 Skin (3) + 
12 Skill (5) + 
M F tUl1l o r. stages III ~ Il d IVa 
13 Skin (5) + 
14 Skin (5) + 
15 Skin (2) + 
Ly illph node + 
16 Lymph node + 
J 7 Skin (5) + 
Seza ry syndro me 
18 Blood + 
19 Blood + 
20 Blood + 
2 1 Blood + 
Ly rnpho blasti c o r imillun o blast ic IYlllph o m a, stage Ie 
22 Skin (5) + 
Lymph node + 
23 Skin (2) + 
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.'? E arl y CTCL = c1 il1icall y sli spiciolls, hi stologica ll y lI o lldiagll osri c po iki lodcr111i c plaques (nos. 1-0) o r cryrhrocil' rllli c lesions (nos. 7. 8); M F = m ycosis fllil go idcs. 
"N 111llbas in pa rentheses in ~ i ca tc th e Ilumbe r of s kill biopsies aV:l ibblc fo r th l,.· gene l\l appin g :lI1 :l lys is ill illdi vidu :d patiellts. Lylllph no de b iopsy s peci m ell s fro m cases 
15. 1 6. and 22 s howed derlllato pathi c IYlllph ad clliris hisrolog ica ll y. 
"' Fo r Ig genes res ulrs were o btain cd w ith m o rc rh:lIl o ll e cnzY I1l t: in 19 of22 G ISCS. Fo r TC (~ bcr;l -ch;lin ge ll L's . results ;l re ex pressed ;l frer d iges ti o ll w ith B;lI11HI. Eco R I 
and Hind lli. respectivel y. I ~ = rea rranged; G = ge rlll iin c (no llrca rran gcd) cOllli g llratio n; and N = no t ana lyzed . 
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region C A probe (C hr 22 lambda 15) [3~], and a T C n. bcta- chain 
gcne pro bc Uurk at bcta 2) [11]. / 
IIlWnll lO}z lovu /il1 G enes: Aliqu ots o f all D NA sa mples w erc di-
ges ted w ith Bam HI and cithcr Econ. 1 o r Hind"l bcfo rc hyb rid-
iza tion w ith th e JH probe. DNA was di gested w ith BamH I prior 
to C K and Hind'" befo re C A probe hybridizat ion . All contro l 
sa mples sho w ed idcnti ca l rcs triction fragmen t pattern s w ith the 
above enzymes and probcs; no ON A po lym o rphisms or rea r-
range ments wcre o bservcd. 
T-Cell Receptor Beta-C hain Gelle: A li quots of all D N A sa mp lcs 
wc re digcs ted w ith Bam HI , Eco HI , and Hind'" befo re hyb rid-
iza tion w ith th e TC R beta-chain gene pro be. Di lu tion ex pcri-
ments havc shown that in o ur hands, this tcchniq uc ca n detcct a 
T - ccll cl o nc at a 5% level 117]. All control samples showed iden-
tica l pattcrns w ith all cnzy m es . 
A rca rrange m ent was defin ed as havin g occurred if after diges-
tion with res tri cti on endo nucleases a new band was detected o n 
hyb ridiza ti on w ith 1 gcnc probc. Where poss ible, all rca rrange-
m ents were shown usin g at least 2 differcnt res trictio n enzy m es , 
in o rd er to cxcl udc the possibility of abno rm al patterns bcing 
ca used by D NA po lymorphism. 
n.ESULTS 
The results from thc stud y of T C R and Ig genes in skin , blood , 
and lymph nodc specimens fro m 23 patients with a proven or 
suspected diagnosis of CTC L arc summarized in Ta ble I. 
T hc TCn. beta- chain gcnc showed a gcrmlinc (nonrca rranged) 
confi g urati on in all specimens fro m 8 patients with clini ca ll y sus-
pi cio us, but histo logica ll y no ndi agnostic po ikilodcrmi c pl aq ues 
(nos. 1-6, Table I) or erythrodermi c lesio ns (nos. 7-8, Table I). 
A germlinc patten) was also found in all samples from 4 patients 
(nos . 9-12, Table I) with histo logicall y verified cutaneous p laqu e 
stagcs o f M F (Fig 2). 
T hi s was in clear d istin ction to aggressive (i.c., illlmuno blastic 
o r lympho blas tic) variants of CTCL (nos. 22 and 23, Table I) o r 
adva nced stagcs of C T C L (i. e. , Seza ry syndrome, tumor stagcs 
of MF-nos. 13-21 , T able I) in w hi ch the T C R bcta-chain gene 
showed a clonal rea rrangemcnt pattern in all samples (Fig 2), 
includin g 3 lymph nodes biopsies (n os. 15, 16, and 22, Table I) 
in w hi ch hi sto logic exa min ati on had o nl y rcvea led derm atopathic 
ly mphadenitis. 
N o 2 cases o f CTCL showed a simil ar rcarrange m ent pattern, 
but in case 15 an d 22 th e clona l TCR beta-chain rea rrangcment 
pattcrn s werc idcnti ca l fro m skin and lymph node tiss ue. 
Ig heavy- and li ght-chain genes w ere present in a germ line 
config uratio n in all cases w ith the cxceptio n of case 19 (Sezary 
syndro mc) in w hich a cl onal rca rrange mcnt pattern was fo un d 
fo r Ig hcavy- chain gcnes. 
D ISC U SSIO N 
It is generall y acccpted th at thc great maj o rity of m ali gnant lym-
pho m as reprcscnt a monoclonal proli feration o f either B- or T -
Iymphocytcs. Whereas the demonstration of Ig li ght-chain re-
stri ction [26,31] o r clona l rearran gement of Ig gencs [7,8] has 
prov ided a valuable means of docum entin g m o no clona lity in B-
cell lym pho m as, no comparable techniqu e has been available for 
the objective dem onstration o f clo nality in T - cell neoplasms. 
Recentl y, the ava ilability of gene probes for the beta- chain of 
th e TCR [11] has provided a means of dem o nstrating m ono-
clo nali ty in T-cell pro li fcrations by show in g rearran gem ents of 
thi s gene in clonal fash ion in DNA extracted from blood o r tissue 
sa mples (Fig 1). Several recen t reports have used this techniqu e 
to documcnt T - ccll lineage and clonali ty in leukemi as and lym-
pho mas 11 4-18] and ad vanced (tumor) stages ofCTCL [1 9], but 
no prev ious studies have focused on the value o f this m ethod in 
th e dia gnos is of the ea rly stages of CTCL. 
In th e present stud y the config urat ion of the TCR beta-chain 
gene has been in vcsti gated in ski n, blood, and lymph node sam-
ples fro m various types and stages of CTCL in an attempt to 
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Figure 2. Autoradiograph of DNA digested with Hindlll and then hy-
bridized with the TCn. beta-chain probe. T rack C contain s DNA from 
normal blood leukocytes and the oth er tracks contain DNA from sk in 
biopsy specimens from 2 different cases of M F. in cludin g case 13 (tum or 
stage of M F) and case fl (suspected CTC L, see Table I), each numbered 
below relevant track. T he band sizes are shown in ki lobases, the normal 
bands on the "(~"I and the abnormal bands on the lefr of the fig ure. Case 
13 (tumor stage of M F) shows a clonal rca rrangement of the TC n. beta-
chain gene after Hind lll di ges tion, whereas case 8 (suspected CTC L) 
shows no ev idcnce of clonal rea rrangement. 
es tablish w hether this m ethod is useful in thc ea rl y recogniti o n 
of CTCL. T he res ults indica te that aggressivc va ri ants of C TCL 
(i. e., lympho blas ti c or immuno blastic lympho m as) and adva nced 
stages o f C TCL (i. e., Sczary syndro m e, tumor stages of MF) all 
show cl onal rearran ge ments of the T C n. beta-chain gene (includ-
in g hi stolog icall y nondi agnos ti c lymph node lesions). This find-
in g is in keeping with a prev io lls study [1 9] and supports the 
view that in these stages, the di sease is clona l [32] and shows a 
high freq uency of dissem ination to ext racutan eo us sites [33,34]. 
In contrast, the lesio ns o f plaque sta ges of my cosis fun goides 
and ea rly suspected C T C L consistentl y possessed the TCR beta-
chain gene in a germlinc confi guration . This m ay be ex plai ned 
by the fa ct that th e in fi ltratin g T -cells in these lesions are poly-
cl o nal rather th an mono clonal (i. e., they arc no nneo plastic). An 
alternative possibili ty is that in these les ions, abnorm al T-cell 
clones arc prescnt at a level w hi ch is too low to be detected , i.e. , 
they constitutc (if present) less than5 % of the cell s stud ied. H ence, 
in dilution ex perim ents, w e and others have shown that w ith the 
usc of DNA probes specifi c for the TCR beta-chain gene a T -
cell cl o ne ca n be detected at levels down to 5% [17,18]. Whatever 
explanation is co rrect, these findin gs m ay help to ex pl ai n the 
indolent course and favora ble prognosis seen in most ea rly cases 
of CTCL [21, 35]. T hey also offer an ex planation for the close 
immunophenotypic and cell k inetic similarity betwecn these co n-
d itions and beni gn cutaneous T - cell in fi ltrates [3- 6]. 
V O L. SH. NO.6 JUN E 1987 
In conclusion, thi s in ves ti ga tion indi ca tes th at D NA analysis 
of C T C L with T C R beta-chain gene pro bes fo rms a useful sup-
ple mentary technique in docum entin g cx tracuta neous disease in 
ad va nced CTCL. In the ea rl y stages there was no ev idence o f 
clo nality, suggesting that in these les ion s the T -ce ll pro liferati on 
is e ither polyclonal o r contains onl y ver y few monoclonal (i.e., 
n eoplas ti c) cells. 
T h e allth ors arc .emu}i" 10 Proji'ssor Dav id W<,a th ern II 111111 D r . Kristinll T holllsell 
Jor slIpport nlld "II COll ra,erlll e,I/ , Dr. Ta k Mnk JOY rh ,. T-ce ll rcaprO/' probe, olld 
Dr. Tcrcllce Rabbills Jor the Ig gcrl c probes. 
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